Shanghai Tanying, shareholder of Junshi Biotech (01877), reduced its A-share holdings by 12 million shares

Zhitong Finance App News, Junshi Biotech (01877) issued an announcement regarding Shanghai Tanying Investment Partnership (Limited Partnership) (“Shanghai Tanying”) plans to reduce its holdings of the company's shares through bulk transactions. The reduction ratio is no more than 2% of the company's total share capital. The holdings reduction period is from September 5, 2025 to December 4, 2025. As of the disclosure date of this announcement, the time period of the above holdings reduction plan has expired. The company recently received a “Notice Letter on the Results of Shareholding Reduction” issued by Shanghai Tanying. During the holdings reduction plan period, Shanghai Tanying reduced its holdings of the company's A shares by a total of 12 million shares through bulk transactions, accounting for 1.1688% of the company's total share capital.